Cook's peripheral DES set to become first in the US after trial success
This article was originally published in Clinica
Executive Summary
Cook Medical's peripheral drug-eluting stent (DES), Zilver PTX, has been proven superior to bare-metal stents (BMSs) in the treatment of peripheral arterial disease (PAD) in the superficial femoral artery.